Among extra-intestinal cancers’ risk, preliminary data suggest a significantly in-creased risk of small bowel cancers especially in IBD with LS and specifically associated with defects in MLH1 and MSH6. This evidence concerns the gene MLH1 and inflammatory bowel disease.